查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
PTSD（創傷後應激障礙）治療市場：按藥物類別、給藥途徑、年齡組、分銷渠道、地區 - 規模、份額、前景和機會分析，2022-2030 年
市場調查報告書
商品編碼
1181763

PTSD（創傷後應激障礙）治療市場：按藥物類別、給藥途徑、年齡組、分銷渠道、地區 - 規模、份額、前景和機會分析，2022-2030 年

Post-traumatic Stress Disorder Treatment Market, by Drug Class, by Route of Administration, by Age Group, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 183 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

PTSD（創傷後應激障礙）是一種精神疾病，可能由於自然災害、生活危機、交通事故和性虐待而發生在人身上。 PTSD 症狀可能會在 3 個月後甚至一年後出現。 許多患有 PTSD 的人會出現侵入性記憶、迴避、思維的負面變化以及情緒和身體反應的變化等症狀。 例如，親人的突然死亡可能會導致某些人出現 PTSD。 患有創傷後應激障礙的人有更高的危險感。 據美國國家創傷後應激障礙中心稱，估計約有 15% 的越南戰爭退伍軍人和 12% 的海灣戰爭退伍軍人患有創傷後應激障礙。 據美國精神病學協會稱，女性患創傷後應激障礙的可能性是男性的兩倍。 PTSD（創傷後應激障礙）的常用處方藥包括抗抑鬱藥、捨曲林、氟西汀和帕羅西汀。

市場動態

主要市場參與者對 PTSD（創傷後應激障礙）治療的研發活動的增加將在預測期內推動全球 PTSD（創傷後應激障礙）治療市場的增長。預計 例如，2021 年 12 月，製藥公司 Jazz Pharmaceuticals plc. 宣布已招募首位患者參加 2 期臨床試驗。 JZP150 是一種高選擇性脂肪酸□胺水解□ (FAAH) 抑製劑，旨在解決 PTSD（恐懼消退及其錨定受損）的根本原因以及患者的焦慮、失眠和噩夢等相關症狀。

這項研究的主要特點

  • 本報告使用 2021 年作為預測期的基準年：2022-2030 年全球創傷後應激障礙 (PTSD) 治療市場、市場規模（百萬美元）和復合年增長率 (CAGR) (%)進行了詳細分析。
  • 解釋了不同細分市場的潛在創收機會，並描述了針對該市場的有吸引力的投資建議矩陣。
  • 它還提供了有關市場驅動因素和推動因素、機會、新產品發布和批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
  • 全球 PTSD（創傷後應激障礙）治療市場的主要參與者根據公司概況、業績、產品組合、地域分佈、分銷戰略、關鍵發展和戰略等參數進行分析。
  • 本次調查涵蓋的主要公司包括 Jazz Pharmaceuticals plc.、Madrigal Mental Care、Allergan PLC、Otsuka Pharmaceutical Co., Ltd.、apex laboratories Pvt. Ltd.、H. Lundbeck A/S (Lundbeck)、Neurovation Labs、 Inc.、Eli Lilly and Company、GlaxoSmithKline PLC、Sun Pharmaceuticals Pvt Ltd、Bristol-Myers Squibb、Johnson and Johnson、Pfizer Inc.、Aurobindo Inc.、Amneal Pharmaceuticals LLC、Teva Pharmaceuticals Industries Ltd. 和 Mylan Pharmaceuticals（Viatris Inc.） )
  • 這份報告中的見解將使企業營銷人員和高管能夠就未來的產品發布、政府舉措、技術升級、市場擴張和營銷策略做出明智的決策。將是
  • 《全球 PTSD（創傷後應激障礙）療法市場報告》是一份綜合報告，涵蓋了該行業的各種利益，包括投資者、產品製造商、分銷商、供應商、研究和諮詢公司、新進入者和金融分析師。給利益相關者。
  • 利益相關者可以通過用於分析全球 PTSD（創傷後應激障礙）治療市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

  • 調查目的
  • 先決條件
  • 縮寫說明

第二章市場展望

  • 報告內容
    • 市場定義和範圍
  • 執行摘要
    • 市場概況：按藥物類別
    • 按給藥途徑劃分的市場概況
    • 市場概況：按年齡組
    • 市場概況：按分銷渠道
    • 市場概況：按地區
  • 連貫機會圖 (COM)

第 3 章市場動態、法規和趨勢分析

  • 市場動態
    • 司機
    • 約束因素
    • 市場機會
  • 影響分析
  • 市場趨勢
  • 主要發展狀況
  • 產品批准
  • 合夥/合併/收購
  • 監管狀況
  • 害蟲分析
  • 波特五力分析
  • 流行病學
  • 可靠的流水線分析

第 4 章 PTSD（創傷後應激障礙）治療的全球市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • 總體影響
  • COVID-19 對市場的影響

第 5 章全球創傷後應激障礙 (PTSD) 治療市場，按藥物類別，2017-2030

  • 2022 年和 2030 年市場份額分析 (%)
  • 2017-2030 年同比增長率分析
  • 抗抑鬱藥
  • 抗焦慮藥
  • 抗高血壓藥
  • 單胺氧化□ (MAO)
  • 抗精神病藥或第二代抗精神病藥 (SGO)
  • β受體阻滯劑
  • 其他（苯二氮卓類藥物，其他）

第 6 章全球創傷後應激障礙 (PTSD) 治療市場（按給藥途徑）：2017-2030

  • 口服劑
  • 父母代理人
  • 鼻劑

第 7 章按年齡組劃分的全球創傷後應激障礙 (PTSD) 治療市場：2017-2030

  • 兒科
  • 成人
  • 年老

第 8 章全球創傷後應激障礙 (PTSD) 治療市場（按分銷渠道），2017-2030

  • 醫院藥房
  • 零售藥房
  • 在線藥店

第 9 章按地區分列的全球創傷後應激障礙 (PTSD) 治療市場，2017-2030

  • 北美
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲地區
  • 歐洲
  • 英國
  • 德國
  • 意大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 東盟
  • 澳大利亞
  • 韓國
  • 其他亞太地區
  • 中東
  • 海灣合作委員會
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中非
  • 南非

第10章競爭格局

  • 熱圖分析
  • 市場份額分析
  • 公司簡介
    • Jazz Pharmaceuticals plc.
    • Madrigal Mental Care
    • Allergan PLC
    • Otsuka Pharmaceutical Co., Ltd.
    • apex laboratories Pvt. Ltd.
    • H. Lundbeck A/S（Lundbeck）
    • Neurovation Labs, Inc.
    • Eli Lilly and Company
    • GlaxoSmithKline PLC
    • Sun Pharmaceuticals Pvt Ltd
    • Bristol-Myers Squibb
    • Johnson and Johnson
    • Pfizer Inc.
    • Aurobindo Inc.
    • Amneal Pharmaceuticals LLC
    • Teva Pharmaceuticals Industries Ltd.
    • Mylan Pharmaceuticals（Viatris Inc.）

第 11 章章節

  • 參考資料
  • 調查方法介紹
  • 關於出版商
簡介目錄
Product Code: CMI4433

Post-traumatic stress disorder (PTSD) is a psychiatric condition that may occur in people who have witnessed a traumatic shock like natural disaster, a life threatening event, car accident, sexual abuse etc. Symptoms of PTSD may generate after three months or even after a year. Most of the patients suffering from PTSD show symptoms like intrusive memories, avoidance, negative changes in thinking and changes in emotional and physical reactions. For instance, sudden death of a loved one may cause PTSD in some people. People with PTSD have heightened sense of danger. According to the U.S. National centre for PTSD, it is estimated that about 15% of the veterans of Vietnam War and 12% of gulf war veterans have PTSD. According to American Psychiatric Association, women are twice likely to get PTSD as compared to men. Commonly prescribed drugs for post trauma stress disorder includes antidepressants, sertraline, fluoxetine, paroxetine, and others.

Market Dynamics

Increasing research and development activities by the key market players for the treatment of post-traumatic stress disorder is expected to boost the growth of the global post-traumatic stress disorder treatment market over the forecast period. For instance, in December 2021, Jazz Pharmaceuticals plc. a pharmaceutical company, announced that the company had enrolled its first patient in Phase 2 clinical trial evaluating the safety and efficacy of JZP150, an investigational first-in-class small molecule for the treatment of adults with post-traumatic stress disorder (PTSD). JZP150 is a highly selective inhibitor of the enzyme Fatty Acid Amide Hydrolase (FAAH), designed to address the underlying cause of PTSD (impairment of fear extinction and its consolidation), as well as patient's associated symptoms such as anxiety, insomnia, and nightmares.

Key features of the study:

  • This report provides an in-depth analysis of the global post-traumatic stress disorder treatment market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2022 - 2030, considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains an attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global post-traumatic stress disorder treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Jazz Pharmaceuticals plc., Madrigal Mental Care, Allergan PLC, Otsuka Pharmaceutical Co., Ltd., apex laboratories Pvt. Ltd., H. Lundbeck A/S (Lundbeck), Neurovation Labs, Inc., Eli Lilly and Company, GlaxoSmithKline PLC, Sun Pharmaceuticals Pvt Ltd, Bristol-Myers Squibb, Johnson and Johnson, Pfizer Inc., Aurobindo Inc., Amneal Pharmaceuticals LLC, Teva Pharmaceuticals Industries Ltd., and Mylan Pharmaceuticals (Viatris Inc.)
  • Insights from this report would allow marketers and management authorities of companies to make an informed decision for their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global post-traumatic stress disorder treatment market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global post-traumatic stress disorder treatment market

Detailed Segmentation:

  • Global Post-traumatic Stress Disorder Treatment Market, By Drug Class
    • Antidepressants
    • Anti-anxiety
    • Antihypertensive
    • Monoamine Oxidase (MAOs)
    • Antipsychotics or Second Generation Antipsychotics (SGOs)
    • Beta-Blockers
    • Others (Benzodiazepines and Others)
  • Global Post-traumatic Stress Disorder Treatment Market, By Route of Administration:
    • Oral
    • Parenteral
    • Nasal
  • Global Post-traumatic Stress Disorder Treatment Market, By Age Group:
    • Pediatric
    • Adult
    • Geriatric
  • Global Post-traumatic Stress Disorder Treatment Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Post-traumatic Stress Disorder Treatment Market, By Region:
    • North America
      • By Country
    • U.S.
    • Canada
    • Latin America
      • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
    • Middle East
      • By Country
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Jazz Pharmaceuticals plc.*
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Madrigal Mental Care
    • Allergan PLC
    • Otsuka Pharmaceutical Co., Ltd.
    • apex laboratories Pvt. Ltd.
    • Lundbeck A/S (Lundbeck)
    • Neurovation Labs, Inc.
    • Eli Lilly and Company
    • GlaxoSmithKline PLC
    • Sun Pharmaceuticals Pvt Ltd
    • Bristol-Myers Squibb
    • Johnson and Johnson
    • Pfizer Inc.
    • Aurobindo Inc.
    • Amneal Pharmaceuticals LLC
    • Teva Pharmaceuticals Industries Ltd.
    • Mylan Pharmaceuticals (Viatris Inc.)

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Class
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Age Group
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Product Approval
  • Collaboration/Merge/Acquisition
  • Regulatory Landscape
  • PEST Analysis
  • Porter's Five Forces Analysis
  • Epidemiology
  • Robust Pipeline Analysis

4. Global Post-traumatic Stress Disorder Treatment Market- Impact of Coronavirus (Covid-19) Pandemic

  • Overall Impact
  • COVID-19 Impact on the market

5. Global Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2017 - 2030, (US$ Million)

  • Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017- 2030
    • Segment Trends
  • Antidepressants
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Anti-anxiety
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Antihypertensive
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Monoamine Oxidase (MAOs)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Antipsychotics or Second Generation Antipsychotics (SGOs)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Beta-Blockers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others (Benzodiazepines and Others)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Post-traumatic Stress Disorder Treatment Market, By Route of Administration, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Oral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Parenteral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Nasal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Post-traumatic Stress Disorder Treatment Market, By Age Group, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Pediatric
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Adult
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Geriatric
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Retail Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Online Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global Post-traumatic Stress Disorder Treatment Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profile
    • Jazz Pharmaceuticals plc.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Madrigal Mental Care
    • Allergan PLC
    • Otsuka Pharmaceutical Co., Ltd.
    • apex laboratories Pvt. Ltd.
    • H. Lundbeck A/S (Lundbeck)
    • Neurovation Labs, Inc.
    • Eli Lilly and Company
    • GlaxoSmithKline PLC
    • Sun Pharmaceuticals Pvt Ltd
    • Bristol-Myers Squibb
    • Johnson and Johnson
    • Pfizer Inc.
    • Aurobindo Inc.
    • Amneal Pharmaceuticals LLC
    • Teva Pharmaceuticals Industries Ltd.
    • Mylan Pharmaceuticals (Viatris Inc.)
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About Us